Novel mutations in two families with Darier's disease

International Journal of Dermatology

Volumn 46, Issue 1, 2007, Pages 64-67

  Amichai, Boazam ^a   Karpati, M ^b   Goldman, B ^b   Peleg, L ^b  

^a CLALIT HEALTH SERVICES   (Israel)

^b GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); DNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DARIER DISEASE; DNA EXTRACTION; EASTERN EUROPE; ETHNOLOGY; EXON; FAMILY; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENETIC DISORDER; HUMAN; INTRON; JEW; MALE; MISSENSE MUTATION; NONSENSE MUTATION; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

ADULT; CODON, NONSENSE; FEMALE; HUMANS; INFANT; JEWS; KERATOSIS FOLLICULARIS; MALE; MUTATION, MISSENSE; PEDIGREE; POLYMERASE CHAIN REACTION; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 33845944195     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.03049.x     Document Type: Article

References (17)

1. Burge S, Wilkinson J. Darier-White disease: A review of the clinical features in 163 patients. J Am Acad Dermatol 1992; 27: 40-50.
2. Sakuntabhai A, Burge S, Monk S, et al. Spectrum of novel ATP2A2 mutation in patients with Darier's disease. Hum Mol Genet 1999; 8: 1611-1619.
3. Munro CS. The phenotype of Darier's disease: Penetrance and expressivity in adults and children. Br J Dermatol 1992; 127: 126-130.
4. Clapham DE. Calcium signaling. Cell 1995; 80: 259-268.
5. Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998; 392: 933-936.
6. Lytton J, MacLennan DH. Molecular cloning of cDNAs from human kidney coding for two alternatively spliced products of the cardiac Ca2+ATPase gene. J Biol Chem 1988; 263: 15024-15031.
7. Ruiz-Perez VL, Carter SA, Healy E, et al. ATP2A2 mutations in Darier's disease: Various cutaneous phenotypes are associated with mis-sense mutations, but neuropsychiatric features are independent of mutation class. Hum Mol Genet 1999; 8: 1621-1630.
8. Ikeda S, Mayuzumi N, Shigihara T, et al. Mutations in ATP2A2 in patients with Darier's disease. J Invest Dermatol 2003; 121: 475-477.
9. 2 and genotype-phenotype correlation. Exp Dermatol 2001; 10: 19-27.
10. Sakuntabhai A, Ruiz-Perez V, Carter S, et al. Mutations in ATP2A2, encoding a Ca++ pump, cause Darier's disease. Nature 1999; 21: 271-277.
11. Tavadia S, Mortimer E, Munro CS. Genetic epidemiology of Darier's disease: A population study in the west of Scotland. Br J Dermatol 2002; 146: 107-109.
12. Martonosi AN, Piluka S. The stracture of the Ca++-ATPase of sarcoplasmic reticulum. Acta Biochim Pol 2003; 50: 337-365.
13. Sheridan AT, Hollowood K, Sakuntabhai A, et al. Expression of sarco/ endoplasmic reticulum Ca++-ATPase type 2 isoforms (SERCA2) in normal human skin and mucosa and Darier's disease skin. Br J Dermatol 2002; 147: 670-674.
14. Dhitavat J, Fairclough RJ, Hovnanian A, et al. Calcium pumps and keratinocytes: Lessons from Darier's disease and Hailey-Hailey disease. Br J Dermatol 2004; 150: 821-828.
15. Axelsen KB, Palmgren MG. Evolution of substrate specificities in the P-type ATPase superfamily. J Mol Evol 1998; 46: 84-101.
16. 2+-ATPase. J Mol Biol 2002; 316: 201-211.
17. 2 gene in Taiwanese patients with Darier's disease. Br J Dermatol 2002; 146: 958-963.